Giles Lisa M. 4
4 · HCW Biologics Inc. · Filed Jun 17, 2022
Insider Transaction Report
Form 4
Giles Lisa M.
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-15+41,841→ 41,841 totalExercise: $2.39Exp: 2032-06-14→ Common Stock (41,841 underlying)
Footnotes (1)
- [F1]100% of the total number of shares subject to the Option shall vest and become exercisable on the earlier of (a) June 15, 2023 or (b) the next annual meeting of stockholders, subject to the Reporting Person continuing to provide services through the vesting date.